Loefflers syndrome differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 23: | Line 23: | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam 2 | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam 2 | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam 3 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam 3 | ||
Line 33: | Line 33: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Increased Eosinophil count | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Increased Eosinophil count | ||
(Mild to moderate) | (Mild to moderate) | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ELISA | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CXR | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 2 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 2 | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3 | ||
Line 44: | Line 44: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Transpulmonary | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Transpulmonary | ||
passage of larvae (Loffler's syndrome) | passage of larvae (Loffler's syndrome) | ||
| style="background: #F5F5F5; padding: 5px;" |Cough | |||
Sputum production | |||
Wheezing | |||
Fever | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 53: | Line 60: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Round or oval opacities (several millimeters to several centimeters) | |||
* In both lungs | |||
* Generally present when blood eosinophilia exceeds 10% | |||
* Migratory | |||
* May become confluent in perihilar areas | |||
* Generally clear spontaneously | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 139: | Line 151: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" |Eosinophilia is prominent in the early stages of disease but minimal with established disease | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 288: | Line 299: | ||
!Increased Eosinophil count | !Increased Eosinophil count | ||
(Mild to moderate) | (Mild to moderate) | ||
! | !ELISA | ||
!Imaging 1 | !Imaging 1 | ||
!Imaging 2 | !Imaging 2 |
Revision as of 19:03, 20 May 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
Loeffler syndrome must be differentiated from other diseases that cause pulmonary eosinophilia, such as Churg-Strauss, drug and toxin-induced eosinophilic lung diseases, other helminthic and fungal infection related eosinophilic lung diseases, and nonhelminthic infections such as Coccidioidomycosis, and Mycobacterium tuberculosis.
Differentiating Loeffler syndrome from other pulmonary eosinophilia syndromes on the basis of etiology.
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||||
Lab Findings | Imaging | Histopathology | ||||||||||||||
Physical exam 2 | Physical exam 3 | Increased Eosinophil count
(High) |
Increased Eosinophil count
(Mild to moderate) |
ELISA | CXR | Imaging 2 | Imaging 3 | |||||||||
Helminthic
and fungal infection-related eosinophilic lung diseases |
Transpulmonary
passage of larvae (Loffler's syndrome) |
Cough
Sputum production Wheezing Fever |
|
| ||||||||||||
Tropical
pulmonary eosinophilia |
40 to 70 percent |
| ||||||||||||||
Allergic bronchopulmonary aspergillosis | * | |||||||||||||||
Heavy
hematogenous seeding with helminths |
| |||||||||||||||
Pulmonary parenchymal invasion | Eosinophilia is prominent in the early stages of disease but minimal with established disease |
| ||||||||||||||
Nonhelminthic infections | Coccidioidomycosis | |||||||||||||||
Mycobacterium tuberculosis | ||||||||||||||||
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) | * | |||||||||||||||
Drug- and toxin-induced eosinophilic lung diseases | * |
| ||||||||||||||
Acute eosinophilic pneumonia | ||||||||||||||||
Chronic eosinophilic pneumonia | ≥40 percent | |||||||||||||||
Idiopathic acute eosinophilic pneumonia | ≥25 percent | |||||||||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Increased Eosinophil count
(High) |
Increased Eosinophil count
(Mild to moderate) |
ELISA | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings | |
Sarcoidosis | * | |||||||||||||||
Pulmonary Langerhans cell histiocytosis (Histiocytosis X) | * | |||||||||||||||
Idiopathic pulmonary fibrosis | <10 percent | |||||||||||||||
Differential Diagnosis 7 |